A common recurring theme for the beginning of the 21st century has been the threat of a highly virulent and/or contagious microorganism spreading to high density population centers across the globe. SARS, various strains of influenza, Ebola, etc. have all had been variations of the same theme: a dangerous yet regionally isolated microorganism spreads due to rapid international travel. This is espe
cially apparent in the most recent Ebola and Zika outbreak for several reasons. First, the countries in West Africa and South American countries most afflicted by the outbreak have had their own health facilities augmented by the international community through nonprofits and foreign militaries. While additionally, the healthcare system needs more cost effective and efficient procedures for the detection of more routine harmful microorganisms. For example, the child complaining of a sore throat and fever or a patient with symptoms consistent with a MRSA infection would require various tests to identify the cause of illness. These current tests are costly demanding both lab resources and personnel that could be put toward the completion of other ends. AI&I Corp.’s Dr. Laser will serve as a more efficient, cost effective solution for the detection of dangerous microorganisms in biological samples and the environment. With little training, any health professional could insert a biological sample into our device and receive a result without any need to grow a culture or have complicated results deciphered by a specialist. Our device will, without any need for human involvement, scan an inserted biological sample reading the DNA/RNA/functional groups of all given biological material. While scanning, the device compares the given biological sample against a database of known pathogens and safe biological material. Once the scan is complete, the device will provide an analysis of the sample listing the presence of any harmful microorganisms. Dr. Laser's proprietary software will perform the test as well as provide a diagnosis, which includes the density or the concentration of microorganisms and blood components that are present and which drug(s) to administer and at what concentrations thus completing the test with only the absolute minimum amount of human input possible, i.e. obtaining a sample of biological material. This lack of human involvement greatly decreases chances of error, cost, and drug resistant strains of microorganisms.
